Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2006
12/13/2006EP1729792A2 Y4 selective receptor agonists for therapeutic interventions
12/13/2006EP1729790A1 Amphipathic glycopeptides
12/13/2006EP1729787A1 Method of proliferating precursor cells
12/13/2006EP1729780A2 Methods for protein production
12/13/2006EP1729570A1 Ion channel
12/13/2006EP1729569A1 TRANSGENIC MODEL FOR ALZHEIMER’S DISEASE
12/13/2006EP1615670A4 Targets for tumor growth inhibition
12/13/2006EP1551441B1 Peptides and recombinant proteins mimicking interferons
12/13/2006EP1534836B1 Mutant forms of meningococcal adp-ribosylating toxin
12/13/2006EP1482975B1 Prevention of tissue adhesion
12/13/2006EP1434790B1 Calcium-influx inhibitory factor and method of isolation thereof
12/13/2006EP1373530B1 Protein kinase stress-related protein and methods of use in plants
12/13/2006EP1354204B1 Hcv antigen/antibody combination assay
12/13/2006EP1343896B1 Small acid-soluble spore protein and uses thereof
12/13/2006EP1338651B1 Method of screening remedy for diabetes
12/13/2006EP1329462B1 Method of producing human serum albumin involving heating step
12/13/2006EP1290201B1 Recombinant subunit proteins from porcine parvovirus produced in plants
12/13/2006EP1287133B1 Regulation of human dopamine-like g protein-coupled receptor
12/13/2006EP1268808B1 Mutants of lactobacillus casei defective in carbon catabolism regulation
12/13/2006EP1261712B1 Proteins named fctrx and nucleic acids encoding same
12/13/2006EP1229114B1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin
12/13/2006EP1206554B1 Activatable recombinant neurotoxins
12/13/2006EP1179067B1 Neuroprotective properties of gdf-15, a member of the tgf-beta superfamily
12/13/2006EP1171605B1 Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof
12/13/2006EP1143989B1 Exendins for glucagon suppression
12/13/2006EP1140156B1 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
12/13/2006EP1124961B1 Thrombopoietic compounds
12/13/2006EP1123392B1 Prv-1 gene and the use thereof
12/13/2006EP1121441B1 Selectively replicating viral vectors
12/13/2006EP1121151B1 Anti-inflammatory alpha2, beta1 integrin-related substances or antibodies
12/13/2006EP1117803B1 Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus
12/13/2006EP1117795B1 Tgf-beta superfamily mutant members, including morphogenic proteins
12/13/2006EP1108786B1 Novel collectin
12/13/2006EP1078078B1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages
12/13/2006EP1011704B1 Tumor necrosis factor receptor-derived peptide analogues
12/13/2006EP0991662B1 Chlamyidia trachomatis specific peptides and their use in diagnostic assays
12/13/2006EP0980429B1 Human toll-like receptor proteins, related reagents and methods
12/13/2006EP0979276B1 Complement receptor type 1 (cr1)-like sequences
12/13/2006EP0968284B1 An improved method for the production and purification of adenoviral vectors
12/13/2006EP0875251B1 Therapeutic agent for treatment of fiv infections
12/13/2006EP0809695B1 Transcription factor - e2f-5
12/13/2006EP0760602B1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/13/2006EP0758401B1 Dry prothrombin time assay
12/13/2006CN1878871A IL-1 receptor based antagonists and methods of making and using
12/13/2006CN1878870A Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis
12/13/2006CN1878869A Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis
12/13/2006CN1878867A Recombinant peptide vector comprising the gene for treatment for autoimmune diseases
12/13/2006CN1878865A Cell-free notch cleavage analysis method and drug screening method
12/13/2006CN1878793A Monoclonal antibodies against HMGB1
12/13/2006CN1878791A 合成的抗微生物多肽 Synthetic antimicrobial polypeptides
12/13/2006CN1878790A Neutralizable epitope of HGF and neutralizing antibody binding to the same
12/13/2006CN1878789A Human cathelicidin antimicrobial peptides
12/13/2006CN1878784A Motoneuronotrophic factor gene sequences
12/13/2006CN1878570A Stable pharmaceutical composition comprising granulocyte-colony stimulating factor
12/13/2006CN1876817A Production method for human tumor necrosis factor TNF-alpha mutant
12/13/2006CN1876816A Fatty acid binding protein gene of Helicoverpa assulta and application thereof
12/13/2006CN1876682A Transferin (Tf)- nerve growth factor (NGF) conjugate preparation method
12/13/2006CN1876681A Cancer-suppressing protein and its gene and uses
12/13/2006CN1876680A Recombinant solenopsis invicta sensitized toxin protein and its uses
12/13/2006CN1876679A Compounds from moraxella catarrhalis
12/13/2006CN1876678A Retroviral resistant polypeptide and its preparing method
12/13/2006CN1876675A Polyacrylamide gel electrophoresis method for wheat low molecular weight glutenin subunit
12/13/2006CN1289674C DNA vaccine-PCV
12/13/2006CN1289673C Anemone neurotoxin gene Sr6 and application thereof
12/13/2006CN1289672C Hippocampus protease inhibitor gene and its use
12/13/2006CN1289670C Polynucleotide useful for modulating cancer cell proliferation
12/13/2006CN1289664C EPSP synthase of variable halomonas high resistance glyphosate and its encoding sequence
12/13/2006CN1289528C Recombinant human interferon-alpha 1b compound and process for preparation
12/13/2006CN1289527C Horny cell growth factor mutant with high bioactivity and its preparation process and use thereof
12/13/2006CN1289526C Stem cell factor
12/13/2006CN1289525C T2R-novel family of taste receptors
12/13/2006CN1289524C Human telomerase active inhibitor protein and use thereof
12/13/2006CN1289523C Paddy rice potassium, sodium ion transport gene and its application
12/13/2006CN1289522C Zinc finger domain libraries
12/13/2006CN1289098C Vesicular stromatitis virus (VSV)
12/12/2006US7148406 Genes encoding enzymes for lignin biosynthesis and uses thereof
12/12/2006US7148405 Enzymes responsible for the metabolism of cis-zeatin
12/12/2006US7148404 Antimicrobial polypeptides
12/12/2006US7148402 Expressing a nucleic acid encoding a PGA37 polypeptide in the plant cell, tissue, organ, callus or cell culture
12/12/2006US7148398 Disease resistance
12/12/2006US7148397 Expression vector comprising nucleotide sequences coding nucleotide binding site-leucine-rich repeat proteins (NBS-LRRP) for use as tool in generation of fungus/disease resistant plants
12/12/2006US7148341 Adenovirus associated nucleotide sequences; for use as gene transfer tool in genetic engineerinf in the
12/12/2006US7148337 drug target and diagnostic marker for prostate cancer; host cells and expression vectors
12/12/2006US7148336 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acid levels
12/12/2006US7148334 Composition for protecting proteins degradation comprising small heat shock proteins (sHSPs) and method of two-dimensional gel electrophoresis using the sHSPs
12/12/2006US7148333 Stabilization; administering by injection
12/12/2006US7148330 Nucleotide sequences for use in the diagnosis of inflammatory, immunological and nervous system disorders
12/12/2006US7148328 Compositions and methods for regulating autolytic processes in bacteria
12/12/2006US7148327 Reacting a keratin source with oxidative sulfitolysis to produce solids comprising reaction product in digestion liquor, separating the solids from the digestion liquor, extracting the solids with a composition consisting of water or water and surfactant and separating extract from solids, recovering
12/12/2006US7148326 Tumor antigen
12/12/2006US7148325 Preferential polypeptide for us e in the treatment of viral disesaes
12/12/2006US7148324 Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation
12/12/2006US7148323 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
12/12/2006US7148321 Particularly relates to antibodies and fusion proteins in which a hinge region derives from one isotype and the CH2 domain derives from a different isotype
12/12/2006US7148202 Receptor-mediated gene delivery using bacteriophage vectors
12/12/2006US7148196 A peptide having the amino acid sequence proline, histidine, serine, arginine, and asparagine
12/12/2006US7148193 Polypeptides for binding hormone receptors for detection of growth receptors for cattle or humans
12/12/2006US7148190 Haptotactic peprides
12/12/2006US7148065 Non-toxic immune stimulating enterotoxin compositions
12/12/2006US7148061 Identification of a novel domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function